Sign in to view content

Benefits and Value of Treatment for Diabetic Macular Edema

Paul Hahn, MD, PhD, FASRS

Video
Published 2022

Related

Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months
Brittney Statler, MD
Updates from the Field
2020
The Functional Burden of Diabetic Retinopathy in the United States – How Ranibizumab May Shift Treatment Paradigms
Jeffrey R Willis, MD/PhD
On Demand Cases, Courses, and Papers
2017
Employee Engagement and Retention
Aamer Hayat
Updates from the Field
2022

Category: Diabetic Retinopathy

See more